Related Experiment Video

Updated: May 24, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Community-associated methicillin-resistant Staphylococcus aureus endocarditis 'down under': case series and

Nicola J Townell1, Wendy J Munckhof, Graeme Nimmo

  • 1Infection Management Service, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Scandinavian Journal of Infectious Diseases
|March 13, 2012
PubMed

Insights

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) endocarditis is rare, especially in non-intravenous drug users. This study reports five cases in young Australians, highlighting significant morbidity and mortality associated with prevalent local CA-MRSA strains.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Microbiology

Background:

  • Infective endocarditis is a serious complication of Staphylococcus aureus bloodstream infections.
  • Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) endocarditis is infrequently reported, often linked to the USA300 strain in intravenous drug users (IVDUs).

Observation:

  • This study details five cases of CA-MRSA endocarditis in young, previously healthy Australian adults.
  • Four of the five patients were identified as IVDUs.
  • The cases involved two common Australian CA-MRSA strains: PVL-positive ST93 and PVL-negative ST1.

Findings:

  • CA-MRSA endocarditis in this cohort presented with high morbidity, including frequent septic emboli.
  • Three patients required surgical intervention (cardiac surgery).
  • One patient succumbed to the infection.

Implications:

  • These findings underscore the potential for severe outcomes from CA-MRSA endocarditis, even in young, otherwise healthy individuals.
  • The involvement of prevalent Australian CA-MRSA strains suggests a need for heightened clinical awareness and surveillance.
  • Further research into risk factors and treatment strategies for CA-MRSA endocarditis is warranted.

More Related Videos

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...